Huntington National Bank’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $51.5K | Sell |
1,868
-196
| -9% | -$5.41K | ﹤0.01% | 1223 |
|
2025
Q1 | $58.5K | Buy |
2,064
+536
| +35% | +$15.2K | ﹤0.01% | 1118 |
|
2024
Q4 | $63.5K | Buy |
1,528
+324
| +27% | +$13.5K | ﹤0.01% | 1104 |
|
2024
Q3 | $80.5K | Sell |
1,204
-588
| -33% | -$39.3K | ﹤0.01% | 983 |
|
2024
Q2 | $213K | Buy |
1,792
+248
| +16% | +$29.5K | ﹤0.01% | 677 |
|
2024
Q1 | $165K | Buy |
1,544
+388
| +34% | +$41.3K | ﹤0.01% | 740 |
|
2023
Q4 | $115K | Sell |
1,156
-1,229
| -52% | -$122K | ﹤0.01% | 809 |
|
2023
Q3 | $246K | Sell |
2,385
-161
| -6% | -$16.6K | ﹤0.01% | 596 |
|
2023
Q2 | $309K | Buy |
2,546
+335
| +15% | +$40.7K | ﹤0.01% | 572 |
|
2023
Q1 | $340K | Buy |
2,211
+684
| +45% | +$105K | ﹤0.01% | 527 |
|
2022
Q4 | $274K | Buy |
1,527
+515
| +51% | +$92.5K | ﹤0.01% | 569 |
|
2022
Q3 | $120K | Buy |
1,012
+139
| +16% | +$16.5K | ﹤0.01% | 717 |
|
2022
Q2 | $124K | Sell |
873
-219
| -20% | -$31.1K | ﹤0.01% | 735 |
|
2022
Q1 | $188K | Buy |
1,092
+620
| +131% | +$107K | ﹤0.01% | 663 |
|
2021
Q4 | $119K | Buy |
472
+153
| +48% | +$38.6K | ﹤0.01% | 804 |
|
2021
Q3 | $122K | Buy |
319
+79
| +33% | +$30.2K | ﹤0.01% | 708 |
|
2021
Q2 | $56K | Hold |
240
| – | – | ﹤0.01% | 913 |
|
2021
Q1 | $31K | Sell |
240
-110
| -31% | -$14.2K | ﹤0.01% | 994 |
|
2020
Q4 | $36K | Hold |
350
| – | – | ﹤0.01% | 919 |
|
2020
Q3 | $25K | Buy |
350
+250
| +250% | +$17.9K | ﹤0.01% | 973 |
|
2020
Q2 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 1295 |
|